Health Dictionary Find a Doctor

Cystitis

For patient information click here.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maliha Shakil, M.D. [2], Usama Talib, BSc, MD [3], Sadaf Sharfaei M.D.[4]

Synonyms and keywords: Ketamine cystitis; Traumatic cystitis; Cystitis cystica; Bladder infection

Overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Steven C. Campbell, M.D., Ph.D.; Associate Editor(s)-in-Chief: Maliha Shakil, M.D. [2], Usama Talib, BSc, MD [3], Sadaf Sharfaei M.D.[4]

Overview

Cystitis is defined as inflammation of the urinary bladder. When caused by an infection, cystitis is classified as a type of the lower UTI. Cystitis results mostly from ascending infections from the urethra but can also result from descending infections from the blood or the lymphatic system. The condition more often affects women, but can affect either gender and all age groups. Urinary tract infections have been described since 1550 BC. In 1836 the earliest record of interstitial cystitis without the presence of a bladder stone were published. Cystitis may be classified according to the etiology and therapeutic approach into various subtypes including: traumatic, interstitial, eosinophilic, hemorrhagic cystitis, and cystitis cystica. For the purpose of treatment, cystitis may also be classified into acute uncomplicated, complicated, and recurrent cystitis. Cystitis occurs when the normally sterile lower urinary tract (urethra and bladder) is infected by bacteria, which leads to irritation and inflammation. Females are more prone to the development of cystitis because of their relatively shorter urethra. Complicated cystitis is due to the obstruction and stasis of urine flow. More than 85% of cases of cystitis are caused by escherichia coli (E. coli), a bacterium found in the lower gastrointestinal tract. Other causes of cystitis include certain medications, diabetes, crohn’s disease, iatrogenic causes, endometriosis, pelvic inflammatory disease, urinary obstruction, and bladder incontinence. Cystitis must be differentiated from other causes of dysuria. Approximately 50% of patients with acute uncomplicated cystitis will recover without treatment within a few days or weeks. If left untreated, some patients with cystitis may progress to develop recurrent infection, pyelonephritis, hematuria, and rarely renal failure. Prognosis is generally good. The majority of patients with cystitis do not have recurrence or complications after treatment. Patients with cystitis are usually well-appearing. Common physical examination findings of cystitis include fever and suprapubic tenderness. Antimicrobial therapy is indicated in cystitis. The treatment of cystitis depends on the disease course (acute uncomplicated vs. complicated) and the rates of resistance in the community. Preventative measures to avoid cystitis include abstinence from sexual activity, use of barrier contraception during sexual intercourse, increasing fluid intake and frequency of urination, and use of estrogen (among postmenopausal women).

Historical Perspective

Urinary tract infections have been described since ancient times with the first documented description in the Ebers Papyrus dated to 1550 BC. In 1836, Joseph Parrish published about interstitial cystitis by describing three cases of severe lower urinary tract symptoms without the presence of a bladder stone. Dr. Alexander Skene in 1887 used the term “interstitial cystitis” to describe the disease.

Classification

Cystitis may be classified according to the etiology and therapeutic approach into various subtypes such as traumatic, interstitialeosinophilichemorrhagic cystitisforeign body, emphysematous, and cystitis cystica. Cystitis can also be classified as acute or chronic depending on the duration of the infection. For the purpose of treatment, cystitis may also be classified into acute uncomplicated, complicated, and recurrent cystitis. It can be classified as bacterialviralfungal or parasitic depending on the causative pathogen.

Pathophysiology

Urine is normally sterile due to the low pH and unidirectional flow of urine that does not allow bacteria to grow and invade the urinary tract. Cystitis occurs when the normally sterile lower urinary tract (urethra and bladder) is either infected by bacteria or rarely a fungus, which leads to irritation and inflammation. Irritation followed by inflammation can also occur in response to trauma, chemicals or foreign bodies. Females are more prone to the development of cystitis because of their relatively shorter and straighter urethra. Bacteria does not have to travel as far to enter the bladder, which is in part due to the relatively short distance between the opening of the urethra and the anus. The pathogenesis of complicated cystitis include obstruction and stasis of urine flow. Normal flow of urine washes away the pathogens and clears the tract. Obstruction leads to overdistension and bacterial growth is facilitated by the residual urine. Stasis of urine flow allows entry of pathogens into the urinary tract.

Causes

Infections are the most common cause of cystitis. More than 80% of cases of cystitis are caused by Escherichia coli (E. Coli), a bacterium found in the lower gastrointestinal tract. Some virusesfungi and parasites can rarely cause cystitis. Other causes of cystitis include certain medications, iatrogenic causes, pelvic inflammatory diseasetrauma, and radiation therapy.

Differential Diagnosis

Cystitis must be differentiated from other causes of dysuria such as acute pyelonephritis, urethritis, prostatitis, vulvovaginitis, urethral strictures or diverticula, benign prostatic hyperplasia and neoplasms such as renal cell carcinoma and cancers of the bladder, prostate, and penis.

Epidemiology and Demographics

Urinary tract infections are found more frequently in women than in men. It is estimated that more than 30% of women will experience at least one episode of cystitis. Of these 30%, 20% women will have recurrent cystitis. The case-fatality rate/mortality rate of uncomplicated cystitis is approximately zero. Females are more commonly affected with cystitis than males. The female to male ratio is 4 to 1. Acute uncomplicated cystitis commonly affects women ages 18-39 years. There is no racial predilection to cystitis. Cystitis is a common disease that affect everyone, mostly women, worldwide.

Risk Factors

Common risk factors in the development of cystitis include female gender, sexual intercourse, diabetes, pregnancy, catheterization, fecal incontinence, old age, and immobility. Some foods are thought to have a role in increasing the risk of cystitis such as vitamin C, coffee or tea, carbonated and alcoholic drinks, citrus fruit, or spicy foods.

Screening

Screening is not recommended for cystitis in a general population. However, pregnancy is an indication for screening for the presence of bacteria in the urine, as this may require aggressive treatment unlike other settings. Other situations that require screening for asymptomatic bacteriuria are prior to urologic surgery or for the research purposes.

Natural History, Complications, and Prognosis

Approximately 50% of patients with acute uncomplicated cystitis will recover without treatment within a few days or weeks. If left untreated, some patients with cystitis may progress to develop recurrent infectionpyelonephritishematuria, and rarely renal failure. Prognosis is generally good. The majority of patients with cystitis do not have recurrence or complications after treatment.

Diagnosis

Diagnostic Study of Choice

Acute uncomplicated typical cystitis is mainly diagnosed based on clinical presentation. Patients with classic symptoms including dysuria, frequency, urgency, and/or suprapubic pain may not need any diagnostic studies. Patients with atypical symptoms might require urinalysis and urine culture to confirm cystitis.

History and Symptoms

A detailed and thorough medical history from the patient is necessary. Specific areas of focus when obtaining a history from the patient include use of urinary catheters,pregnancy, sexual history, diabetes, recent antibiotic use, history of renal disease, urinary incontinence, and urinary retention. Symptoms of cystitis include painful urination, abnormal urine color (cloudy), blood in the urine, frequent urination or urgent need to urinate, or pressure in the lower pelvis.

Physical Examination

Patients with cystitis are usually well-appearing. Common physical examination finding of cystitis includes suprapubic tenderness. A focused physical examination is helpful in confirming the suspicion of cystitis and in ruling out alternate pathology.

Laboratory Findings

Presence of signs and symptoms of cystitis like dysurianocturiafrequency and urgency increase the probability of confirmation of cystitis as the diagnosis. Laboratory tests used in the diagnosis and confirmation of cystitis include urinalysis and urine culture. Laboratory findings consistent with the diagnosis of cystitis include pyuria and either white blood cells (WBCs) or red blood cells (RBCs) on urinalysis and a positive urine culture.

Electrocardiogram

There are no ECG findings associated with cystitis.

X-ray

X ray is not usually done to diagnose cystitis. An x ray of KUB (Kidneys, ureters, and bladder) is done to probe the suspicion for emphysematous cystitis. In case of emphysematous cystitis, it can show presence of gas in the bladder wall. Sometimes, an x ray that is taken for another reason, might reveal gas in the urinary bladder and thus lead to the diagnosis of emphysematous cystitis.

Echocardiography and Ultrasound

There are no echocardiography findings associated with cystitis. Ultrasonography is not done routinely to diagnose cystitis. Ultrasonography is sometimes done to diagnose the suspicion of emphysematous cystitis and for detecting the presence of tumors or stones. Imaging findings for chronic hemorrhagic cystitis due to radiation or chemotherapyinclude a small fibrosed bladder with a thick wall and resultant hydronephrosisCalcification is only rarely seen.

CT scan

In case of emphysematous cystitis, a CT scan of the abdomen can show presence of gas in the bladder wall. CT scan done while looking for other causes of abdominal pain, sometimes reveal gas directing the bladder wall and thus the diagnosis of emphysematous cystitis. CT scan may not be that useful in other causes of cystitis.

MRI

MRI is not used in the routine diagnosis of cystitis. An MRI can help diagnose a tumor or a stone in the bladder that is leading to stasis and thus to the inflammation and infection of the bladder. Inflammation and edema can also be noticed by the help of an MRI. MRI is sometimes used to diagnose cystitis glandularis. Imaging findings for chronic hemorrhagic cystitis due to radiation include a fibrosed bladder with a thick wall, hydronephrosis and rarely, calcifications.

Other Imaging Findings

There are no other imaging findings associated with cystitis.

Other Diagnostic Studies

Cystoscopy is not usually done to diagnose cystitis. Cystoscopy is recommended in recurrent cystitis, emphysematous cystitis, cystitis in children less than 2 years or in any kind of cystitis with normal routine tests. Hunter lesions can be identified using cystoscopy in patient with interstitial cystitis or bladder pain syndrome. Cystoscopy may sometime require the administration of local anaesthesia to facilitate the process. Mass spectrometry based metabolomic analysis is useful in detecting urinary metabolites in Interstitial cystitis.

Treatment

Medical Therapy

A major proportion of the urinary tract infections resolves on its own if left untreated. Complications can occur but not very frequently. Cystitis can though increase morbidity and the goal of therapy is early resolution of infectious symptoms. Antimicrobial therapy is indicated in cystitis. The treatment of cystitis depends on the disease course (acute uncomplicated vs complicated) and the rates of resistance in the community. Due to the risk of the infection spreading to the kidneys (complicated UTI) and the high complication rate in diabetics and the elderly population, prompt treatment is almost always recommended. The increasing resistance to various drugs is a growing challenge. One aspect of increasing drug resistance is the gram negative bacteria population that produces extended spectrum beta lactamase. Hyperbaric oxygen is used to treat hemorrhagic cystitis associated with exposure to radiation and emphysematous cystitis, as presence of gas in the bladder wall interferes with the tissue oxygenation. Proper oxygenation may help to curtail the associated damage.

Interventions

There are no recommended therapeutic interventions for the management of cystitis.

Surgery

Surgery is not the primary treatment for cystitis and is not required most of the times. Surgery can be done for associated pathologies leading to cystitis like a tumor or a stone leading to obstruction of the bladder and thus encouraging growth of pathogens and thus cystitis.

Primary Prevention

Preventative measures to avoid cystitis include the measures for preventing a urinary tract infection which include voiding after intercourse, use of barrier contraception, increasing fluid intake and frequency of urination, and use of estrogen (among postmenopausal women). Single-dose prophylactic antimicrobial therapy prior to sexual intercourse may be administered to patients who have recurrent episodes of cystitis that are associated with sexual activity. Cleaning the urethral meatus after intercourse has also shown to be effective in preventive recurrent cystitis.

Secondary Prevention

Secondary prophylaxis of cystitis is useful to prevent recurrent cystitis. It is more beneficial in patients in which cystitis is associated with sexual intercourse, a structural defect or a disease like diabetes that can lead to recurrent infections.

References

Template:WH Template:WS

Historical Perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Maliha Shakil, M.D. [2], Usama Talib, BSc, MD [3]

Overview

Urinary tract infections have been described since ancient times with the first documented description in the Ebers Papyrus dated to 1550 BC. In 1836, Joseph Parrish published about interstitial cystitis by describing three cases of severe lower urinary tract symptoms without the presence of a bladder stone. Dr. Alexander Skene in 1887 used the term “interstitial cystitis” to describe the disease.

Historical Perspective

References

  1. A-Achi, Antoine. An Introduction to Botanical Medicines: History, Science, Uses, and Dangers: History, Science, Uses, and Dangers. Harvard Medical School.
  2. Moutzouris DA, Falagas ME (2009). “Interstitial cystitis: an unsolved enigma”. Clin J Am Soc Nephrol. 4 (11): 1844–57. doi:10.2215/CJN.02000309. PMID 19808225.
  3. NIDDK Interstitial Cystitis Summary – IC section of the NKUDIC

Template:WH Template:WS

Classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Maliha Shakil, M.D. [2], Usama Talib, BSc, MD [3]

Overview

Cystitis may be classified according to the etiology and therapeutic approach into various subtypes such as traumatic, interstitial, eosinophilic, hemorrhagic cystitis, foreign body, emphysematous, and cystitis cystica. Cystitis can also be classified as acute or chronic depending on the duration of the infection. For the purpose of treatment, cystitis may also be classified into acute uncomplicated, complicated, and recurrent cystitis. It can be classified as bacterial, viral, fungal or parasitic depending on the causative pathogen.

Classification

Cystitis may be classified into several subtypes based on:[1]

Classification according to etiology

There are several medically distinct types of cystitis, each having a unique etiology and therapeutic approach:

Traumatic Cystitis

It is probably the most common form of cystitis in the female, and is due to bruising of the bladder, usually by abnormally forceful sexual intercourse. This is often followed by bacterial cystitis, frequently by coliform bacteria being transferred from the bowel through the urethra into the bladder. Lack of circumcision and intercourse are important risk factors for traumatic cystitis.[1][2]

Interstitial Cystitis

Interstitial cystitis is considered more of an injury to the bladder resulting in constant irritation and rarely involves the presence of infection. IC patients are often misdiagnosed with UTI/cystitis for years before they are told that their urine cultures are negative. Antibiotics are not used in the treatment of IC. The cause of IC is unknown, though some suspect it may be autoimmune where the immune system attacks the bladder. Certain urinary metabolites are being associated with the diagnosis of interstitial cystitis. Chronic interstitial cystitis can lead to changes in the expression of the neuropeptides leading to defected visceral sensations and hyperreflexia of the urinary bladder. Several therapies are now available.[3][4][5]

Eosinophilic Cystitis

It is a rare form of cystitis that is diagnosed by biopsy. In these cases, the bladder wall is infiltrated with a high number of eosinophils. The cause of EC may be attributed to infection by Schistosoma haematobium or by certain medications in afflicted children. Some consider it a form of interstitial cystitis.[6][7][8]

Hemorrhagic Cystitis

Blood in the bladder due to rupture of vessels, trauma, or tumour can act as an irritant and cause cystitis. Hemorrhagic cystitis can occur as a side effect of cyclophosphamide, ifosfamide, exposure to environmental toxins like aniline dyes, pesticides, and radiation therapy.[9] Radiation cystitis, one form of hemorrhagic cystitis is a rare consequence of patients undergoing radiation therapy for the treatment of cancer.[10] Several adenovirus serotypes have been associated with an acute, self-limited hemorrhagic cystitis, which occurs primarily in boys. It is characterized by hematuria, and virus can usually be recovered from the urine.[11][12][13][14]

Foreign Body Cystitis

This is the kind of inflammation of the urinary bladder that can result from foreign bodies like a kidney stone, tumour, contraceptive device, foley catheter, or an infection associated with these foreign bodies. When caused by a benign lesion obstructing the bladder, foreign body cystitis is called papillary or polypoid cystitis.[15][16][17][18]

Cystitis Cystica

This is a chronic cystitis glandularis accompanied by the formation of cysts. This disease can cause chronic urinary tract infections. It appears as small cysts filled with fluid and lined by one or more layers of epithelial cells. These are due to hydropic degeneration in the center of Brunn’s nests.[19][20]

Emphysematous Cystitis

Emphysematous cystitis is associated with production of gas and is mostly caused by E Coli and klebsiella pneumoniae.[21]

Cystitis Glandularis

This is a premalignant type of cystitis. It is considered to be a precursor of adenocarcinoma of the bladder.[22]

Ketamine Cystitis

This kind of cystitis is caused by the anaesthetic agent, ketamine, which causes urothelial dysfunction.[23]

Classification according to pathogen

Cystitis can be classified according to the causative organisms.[24][25][26][27][28]

Classification according to duration and treatment

Cystitis may be classified based on the duration of infection and the treatment:

Acute uncomplicated cystitis[36]

  • Patients with acute uncomplicated cystitis have an infection that is restricted to the lower urinary tract and is most commonly seen in women with normal structure and function of the genitourinary tract and children older than age 2 years. Acute Urinary infections in men are always managed as complicated infections.
  • Patients with acute uncomplicated cystitis may be treated using a single antimicrobial therapy using either a single dose or a 3-day regimen.

Complicated cystitis[37][38]

  • Complicated urinary tract infections occur irrespective of age and gender in people who have either functional or structural malformations. Urinary tract infection in elderly men is always considered complicated.
  • Patients with complicated cystitis generally require a longer duration of therapy compared with patients with uncomplicated cystitis.

Recurrent/Chronic cystitis[5][39][40][41][42]

References

  1. 1.0 1.1 Hooton TM, Stamm WE (1997). “Diagnosis and treatment of uncomplicated urinary tract infection”. Infect Dis Clin North Am. 11 (3): 551–81. PMID 9378923.
  2. Aydos MM, Memis A, Yakupoglu YK, Ozdal OL, Oztekin V (2001). “The use and efficacy of the American Urological Association Symptom Index in assessing the outcome of urethroplasty for post-traumatic complete posterior urethral strictures”. BJU Int. 88 (4): 382–4. PMID 11564026.
  3. Kind T, Cho E, Park TD, Deng N, Liu Z, Lee T; et al. (2016). “Interstitial Cystitis-Associated Urinary Metabolites Identified by Mass-Spectrometry Based Metabolomics Analysis”. Sci Rep. 6: 39227. doi:10.1038/srep39227. PMC 5156939. PMID 27976711.
  4. Friedlander JI, Shorter B, Moldwin RM (2012). “Diet and its role in interstitial cystitis/bladder pain syndrome (IC/BPS) and comorbid conditions”. BJU Int. 109 (11): 1584–91. doi:10.1111/j.1464-410X.2011.10860.x. PMID 22233286.
  5. 5.0 5.1 Vizzard MA (2001). “Alterations in neuropeptide expression in lumbosacral bladder pathways following chronic cystitis”. J Chem Neuroanat. 21 (2): 125–38. PMID 11312054.
  6. Kilic O, Akand M, Gul M, Karabagli P, Goktas S (2016). “Eosinophilic Cystitis: A Rare Cause of Nocturnal Enuresis in Children”. Iran Red Crescent Med J. 18 (6): e24562. doi:10.5812/ircmj.24562. PMC 5002967. PMID 27621918.
  7. Okazaki S, Hori J, Kita M, Yamaguchi S, Kawakami N, Kakizaki H (2014). “[A case of eosinophilic cystitis mimicking an invasive bladder cancer]”. Hinyokika Kiyo. 60 (12): 635–9. PMID 25602481.
  8. Leutscher PD, Pedersen M, Raharisolo C, Jensen JS, Hoffmann S, Lisse I; et al. (2005). “Increased prevalence of leukocytes and elevated cytokine levels in semen from Schistosoma haematobium-infected individuals”. J Infect Dis. 191 (10): 1639–47. doi:10.1086/429334. PMID 15838790.
  9. Manikandan R, Kumar S, Dorairajan LN (2010). “Hemorrhagic cystitis: A challenge to the urologist”. Indian J Urol. 26 (2): 159–66. doi:10.4103/0970-1591.65380. PMC 2938536. PMID 20877590.
  10. Wakamiya T, Kuramoto T, Inagaki T (2016). “[Two Cases of Spontaneous Rupture of the Urinary Bladder Associated with Radiation Cystitis, Repaired with Omentum Covering]”. Hinyokika Kiyo. 62 (10): 545–548. doi:10.14989/ActaUrolJap_62_10_545. PMID 27919130.
  11. Russo P (2000). “Urologic emergencies in the cancer patient”. Semin Oncol. 27 (3): 284–98. PMID 10864217.
  12. PHILIPS FS, STERNBERG SS, CRONIN AP, VIDAL PM (1961). “Cyclophosphamide and urinary bladder toxicity”. Cancer Res. 21: 1577–89. PMID 14486208.
  13. Watson NA, Notley RG (1973). “Urological complications of cyclophosphamide”. Br J Urol. 45 (6): 606–9. PMID 4775738.
  14. Cox PJ (1979). “Cyclophosphamide cystitis and bladder cancer. A hypothesis”. Eur J Cancer. 15 (8): 1071–2. PMID 510344.
  15. Cunha BA, Lee P, Kaouris N, Raza M (2015). “The safety of nitrofurantoin for the treatment of nosocomial catheter-associated bacteriuria (CAB) and cystitis”. J Chemother. 27 (2): 122–3. doi:10.1179/1973947814Y.0000000202. PMID 25004793.
  16. Teal SB, Craven WM (2006). “Inadvertent vesicular placement of a vaginal contraceptive ring presenting as persistent cystitis”. Obstet Gynecol. 107 (2 Pt 2): 470–2. doi:10.1097/01.AOG.0000164072.91339.9e. PMID 16449153.
  17. Bilichenko SV, Maĭzel’s IG, Golovina EI, Arkhipov VV (2001). “[Bladder foreign body in a 4-year-old girl]”. Urologiia (3): 42–3. PMID 11505545.
  18. Stamatiou K (2013). “Urinary retention due to benign tumor of the bladder neck in a woman; a rare case of papillary cystitis”. Urologia. 80 (1): 83–5. doi:10.5301/RU.2013.10716. PMID 23423685.
  19. Halder P, Mandal KC, Mukherjee S (2016). “Prolapsing cystitis cystica causing bladder outlet obstruction: An unusual complication”. Indian J Urol. 32 (4): 329–330. doi:10.4103/0970-1591.189718. PMC 5054670. PMID 27843222.
  20. Grimsby GM, Tyson MD, Salevitz B, Smith ML, Castle EP (2012). “Bladder Outlet Obstruction Secondary to a Brunn’s Cyst”. Curr Urol. 6 (1): 50–2. doi:10.1159/000338871. PMC 3783323. PMID 24917712.
  21. Tzou KY, Chiang YT (2016). “Emphysematous Cystitis”. N Engl J Med. 375 (18): 1779. doi:10.1056/NEJMicm1509543. PMID 27806219.
  22. IMMERGUT S, COTTLER ZR (1950). “Mucin producing adenocarcinoma of the bladder associated with cystitis follicularis and glandularis”. Urol Cutaneous Rev. 54 (9): 531–4. PMID 15443228.
  23. Tsai YC, Birder L, Kuo HC (2016). “Abnormal Sensory Protein Expression and Urothelial Dysfunction in Ketamine-Related Cystitis in Humans”. Int Neurourol J. 20 (3): 197–202. doi:10.5213/inj.1632634.317. PMC 5083834. PMID 27706016.
  24. 24.0 24.1 Fihn SD (2003). “Clinical practice. Acute uncomplicated urinary tract infection in women”. N Engl J Med. 349 (3): 259–66. doi:10.1056/NEJMcp030027. PMID 12867610.
  25. 25.0 25.1 Hooton TM (2003). “The current management strategies for community-acquired urinary tract infection”. Infect Dis Clin North Am. 17 (2): 303–32. PMID 12848472.
  26. Czaja CA, Scholes D, Hooton TM, Stamm WE (2007). “Population-based epidemiologic analysis of acute pyelonephritis”. Clin Infect Dis. 45 (3): 273–80. doi:10.1086/519268. PMID 17599303.
  27. Echols RM, Tosiello RL, Haverstock DC, Tice AD (1999). “Demographic, clinical, and treatment parameters influencing the outcome of acute cystitis”. Clin Infect Dis. 29 (1): 113–9. doi:10.1086/520138. PMID 10433573.
  28. de Cueto M, Aliaga L, Alós JI, Canut A, Los-Arcos I, Martínez JA; et al. (2016). “Executive summary of the diagnosis and treatment of urinary tract infection: Guidelines of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC)”. Enferm Infecc Microbiol Clin. doi:10.1016/j.eimc.2016.11.005. PMID 28017477.
  29. Sievert DM, Ricks P, Edwards JR, Schneider A, Patel J, Srinivasan A; et al. (2013). “Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010”. Infect Control Hosp Epidemiol. 34 (1): 1–14. doi:10.1086/668770. PMID 23221186.
  30. Zhanel GG, Walkty AJ, Karlowsky JA (2016). “Fosfomycin: A First-Line Oral Therapy for Acute Uncomplicated Cystitis”. Can J Infect Dis Med Microbiol. 2016: 2082693. doi:10.1155/2016/2082693. PMC 4904571. PMID 27366158.
  31. Kahlmeter G, ECO.SENS (2003). “An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project”. J Antimicrob Chemother. 51 (1): 69–76. PMID 12493789.
  32. Hooton TM (2000). “Pathogenesis of urinary tract infections: an update”. J Antimicrob Chemother. 46 Suppl A: 1–7. PMID 10969044.
  33. 33.0 33.1 Ples R, Méchaï F, Champiat B, Droupy S, Huerre M, Guettier C; et al. (2011). “[Pseudotumoral toxoplasmic cystitis revealing acquired immunodeficiency syndrome]”. Ann Pathol. 31 (1): 46–9. doi:10.1016/j.annpat.2010.11.001. PMID 21349389.
  34. Ronald A (2002). “The etiology of urinary tract infection: traditional and emerging pathogens”. Am J Med. 113 Suppl 1A: 14S–19S. PMID 12113867.
  35. Hemorrhagic cystitis. Pathology Outlines.http://www.pathologyoutlines.com/topic/bladderhemorrhagiccystitis.html Accessed on February 17, 2016
  36. Nicolle LE (2008). “Uncomplicated urinary tract infection in adults including uncomplicated pyelonephritis”. Urol Clin North Am. 35 (1): 1–12, v. doi:10.1016/j.ucl.2007.09.004. PMID 18061019.
  37. Pallett A, Hand K (2010). “Complicated urinary tract infections: practical solutions for the treatment of multiresistant Gram-negative bacteria”. J Antimicrob Chemother. 65 Suppl 3: iii25–33. doi:10.1093/jac/dkq298. PMID 20876625.
  38. Nicolle LE (2001). “A practical guide to antimicrobial management of complicated urinary tract infection”. Drugs Aging. 18 (4): 243–54. PMID 11341472.
  39. Wada K, Uehara S, Ishii A, Sadahira T, Yamamoto M, Mitsuhata R; et al. (2016). “A Phase II Clinical Trial Evaluating the Preventive Effectiveness of Lactobacillus Vaginal Suppositories in Patients with Recurrent Cystitis”. Acta Med Okayama. 70 (4): 299–302. PMID 27549677.
  40. Holland SM, Gallin JI (1998). “Evaluation of the patient with recurrent bacterial infections”. Annu Rev Med. 49: 185–99. doi:10.1146/annurev.med.49.1.185. PMID 9509258.
  41. Arbiser JL (1995). “Genetic immunodeficiencies: cutaneous manifestations and recent progress”. J Am Acad Dermatol. 33 (1): 82–9. PMID 7601952.
  42. Franco AV (2005). “Recurrent urinary tract infections”. Best Pract Res Clin Obstet Gynaecol. 19 (6): 861–73. doi:10.1016/j.bpobgyn.2005.08.003. PMID 16298166.

Template:WH Template:WS

Pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Steven C. Campbell, M.D., Ph.D. Associate Editor(s)-in-Chief: Usama Talib, BSc, MD [2], Maliha Shakil, M.D. [3]

Overview

Urine is normally sterile due to the low pH and unidirectional flow of urine that does not allow bacteria to grow and invade the urinary tract. Cystitis occurs when the normally sterile lower urinary tract (urethra and bladder) is either infected by bacteria or rarely a fungus, which leads to irritation and inflammation. Irritation followed by inflammation can also occur in response to trauma, chemicals or foreign bodies. Females are more prone to the development of cystitis because of their relatively shorter and straighter urethra. Bacteria does not have to travel as far to enter the bladder, which is in part due to the relatively short distance between the opening of the urethra and the anus. The pathogenesis of complicated cystitis include obstruction and stasis of urine flow. Normal flow of urine washes away the pathogens and clears the tract. Obstruction leads to overdistension and bacterial growth is facilitated by the residual urine. Stasis of urine flow allows entry of pathogens into the urinary tract.

Pathophysiology

Acute Uncomplicated Cystitis

  • Acute uncomplicated cystitis is an inflammation of the urinary bladder that occurs in the absence of any structural or functional pathology. In women, vaginal colonization of the uropathogens leads to the development of a urinary tract infection.
  • Cystitis occurs when the normally sterile lower urinary tract (consisting of urethra and bladder) is infected by bacteria and becomes irritated and inflamed.
  • Once bacteria enter the bladder, they are normally removed through urination. When bacteria multiply faster than they are removed by urination, it results in their accumulation leading to an infection.[1][2]

Cystitis is rare in males but when occurs, is predominantly found in homosexual or uncircumscribed individuals.

  • Females are more prone to the development of cystitis because of their relatively shorter urethra.
  • Bacteria do not have to travel as far to enter the bladder, which is in part due to the relatively short distance between the opening of the urethra and the anus.[3][4]

Complicated cystitis

The pathogenesis of complicated cystitis include obstruction and stasis of urine flow.

  • Complicated cystitis is usually a result of an abnormality in the structure or function of the urinary tract.
  • This abnormality can result from various causes like foreign bodies such as:
  • Any process leading to the obstruction leads to over distension and so bacterial growth is facilitated by the residual urine.
  • Stasis of urine flow allows entry of pathogens into the urinary tract and also hinders the natural preventive mechanism by which urine flushes away the pathogens and prevents colonisation in the urinary tract.[1][5][6][7]

Recurrent/Chronic cystitis

Recurrent inflammation of the bladder that is usually due to an infection, needs intensive investigation. Recurrent urinary infections may result from:

The most common pathogen involved in recurrent infections resulting in inflammation of the bladder is E.coli.

  • Chronic inflammation of the urinary bladder can cause alterations in the functional mechanisms and may lead to structural changes.
  • It is understood that recurrent or chronic cystitis can lead to changes in the expression of the neuropeptides like substance P and calcitonn gene-related peptide (CGRP).
  • This manifests as altered sensation of bladder filling called allodynia and hyperreflexia of the urinary bladder due to defect in the agents responsible for regular sensing ability of the bladder. [8][9][10][11][12]

Interstitial Cystitis

The pathogenesis of Interstitial cystitis also known as bladder pain syndrome, includes:[13][14][15][16]

  • Epithelial dysfunction
  • Mast cell activation
  • Bladder sensory nerve up-regulation
  • Organ cross talk

Certain foods have been associated with the interstitial cystitis, some of these include:

  • Spicy foods
  • Citrus fruit
  • Tomatoes
  • Carbonated and alcoholic drinks
  • Coffee or tea
  • Vitamin C

The urothelium acts as a barrier against damage to the bladder. The urothelium produces a mucous layer which regulates the entry of potassium in the bladder interstitium.

  • Damage to the urothelium results in the production of cytokines which activate mast cells in the interstitium.
  • Mast cell activation is further triggered by the diffusion of excess potassium into the bladder interstitium.[17]

Cystitis cystica

Chronic irritation from infection, calculi or even tumors results in metaplasia of the urothelium, which proliferates into buds, which grow down into the connective tissue beneath the epithelium in the lamina propria.

  • In the case of cystitis cystica, the buds then differentiate into cystic deposits.
  • The pathogenesis of cystitis cystica follows a positive feedback mechanism where with each infection there is a greater chance of subsequent changes in the bladder mucosa.
  • Long term chemoprophylaxis and transurethral resection of the bladder are amongst the possible treatment options for cystitis cystica.[18][19][20][21]

Eosinophilic Cystitis

Inflammation of the urinary bladder by infiltration of eosinophils is the core of the process.

Hemorrhagic Cystitis

Hemorrhagic cystitis is associated with hematuria.

  • The hematuria results from rupture of the small mucosal blood vessels that are damaged due to:
  • Treatments targeting eradication of the causative viruses, drugs or metabolites and intravenous hydration that flushes the urinary tract are very effective in treating hemorrhagic cystitis.[23]
  • Several adenovirus serotypes have been associated with an acute, self-limited hemorrhagic cystitis, which occurs primarily in boys.
  • It is characterized by hematuria, and virus can usually be recovered from the urine.[24][25][26][27][28][29]

Traumatic Cystitis

Traumatic cystitis is caused by trauma to the bladder.

  • Damage to the bladder predisposes it to invasion by pathogens that are normally not able to infect the bladder.
  • Traumatic cystitis is a common phenomenon in females and follows invasion of a bruised bladder that follows an abnormally forceful sexual intercourse.
  • Absence of circumcision increase chances of the normal pathogen in the skin to be lodged into the urinary tract, though the evidence is not convincing.
  • Traumatic cystitis can also occur postoperatively in children.
  • Trauma can also lead to stricture formation which in turn leads to stasis of urine and growth of bacteria or viruses in the bladder. [30][31]

Foreign Body Cystitis

Foreign bodies like kidney stones, indwelling catheters, and contraceptive devices can either result in:

Removal of the foreign body and flushing the urinary tract with fluids are very effective treatment options.

  • Polypoid/Papillary cystitis is caused by obstruction of the bladder by a benign tutor that leads to stasis leading to infection and inflammation of the bladder.[32][33][34][35][36][37]

Emphysematous Cystitis

Gas production inside the bladder is the key feature to diagnose emphysematous cystitis. Diabetes has been strongly associated with this emphysematous cystitis.

  • Though the pathogenesis is not exactly understood, high tissue glucose content in a patient with diabetes mellitus and fermentation of glucose in urine are considered to be important mechanisms that facilitate invasion of gas forming bacteria.
  • E.Coli and Klebsiella are amongst the found pathogens.
  • Another important aspect in the pathogeneses of emphysematous cystitis is the imbalance between the accumulation of gas and its clearance.
  • Emphysematous cystitis can be an incidental finding on abdominal imaging done for abdominal pain or any other suspected pathology.
  • Abdominal pain and hematuria can be seen in patients with this disease due to damage caused by gas forming bacteria.
  • Since air accumulation interferes with normal oxygenation of the tissues, provision of hyperbaric oxygen has been associated with improvement of symptoms in patients with emphysematous cystitis.[38][39][40][41][42]

Cystitis Glandularis

Cystitis glandularis is considered a premalignant condition. The following are some significant aspects in the pathogenesis of cystitis glandularis:

Ketamine Cystitis

Ketamine cystitis is a complication of procedures where ketamine is used as anaesthetic agent. Ketamine cystitis differs from other drugs that cause cystitis like cyclophosphamide, ifosfamide and penicillin G, in that it does not cause haemorrhage. The pathogeneses of ketamine cystitis includes urothelial dysfunction by the following mechanisms:[47]

Genetics

Though the genetics of cystitis have not been studied extensively. It is understood that family history of urinary tract infection is a strong risk factor recurrent urinary infections in relatives. This risk is stronger in closer than distant relatives suggesting the role of a genetic component.[8][48]

Associated Conditions

The following conditions can be associated with cystitis.[1][4][49][50]

Gross Pathology

The gross pathology of cystitis does not yield any findings.

Microscopic Pathology

The microscopic pathology helps to confirm the diagnosis and to differentiate different types of cystitis.[51][52]

References

  1. 1.0 1.1 1.2 Hooton TM (2000). “Pathogenesis of urinary tract infections: an update”. J Antimicrob Chemother. 46 Suppl A: 1–7. PMID 10969044.
  2. Nicolle LE (2008). “Uncomplicated urinary tract infection in adults including uncomplicated pyelonephritis”. Urol Clin North Am. 35 (1): 1–12, v. doi:10.1016/j.ucl.2007.09.004. PMID 18061019.
  3. Russell DB, Roth NJ (2001). “Urinary tract infections in men in a primary care population”. Aust Fam Physician. 30 (2): 177–9. PMID 11280121.
  4. 4.0 4.1 Platt R, Polk BF, Murdock B, Rosner B (1986). “Risk factors for nosocomial urinary tract infection”. Am J Epidemiol. 124 (6): 977–85. PMID 3776980.
  5. Pallett A, Hand K (2010). “Complicated urinary tract infections: practical solutions for the treatment of multiresistant Gram-negative bacteria”. J Antimicrob Chemother. 65 Suppl 3: iii25–33. doi:10.1093/jac/dkq298. PMID 20876625.
  6. Nicolle LE (2001). “A practical guide to antimicrobial management of complicated urinary tract infection”. Drugs Aging. 18 (4): 243–54. PMID 11341472.
  7. Lichtenberger P, Hooton TM (2008). “Complicated urinary tract infections”. Curr Infect Dis Rep. 10 (6): 499–504. PMID 18945392.
  8. 8.0 8.1 Franco AV (2005). “Recurrent urinary tract infections”. Best Pract Res Clin Obstet Gynaecol. 19 (6): 861–73. doi:10.1016/j.bpobgyn.2005.08.003. PMID 16298166.
  9. Wada K, Uehara S, Ishii A, Sadahira T, Yamamoto M, Mitsuhata R; et al. (2016). “A Phase II Clinical Trial Evaluating the Preventive Effectiveness of Lactobacillus Vaginal Suppositories in Patients with Recurrent Cystitis”. Acta Med Okayama. 70 (4): 299–302. PMID 27549677.
  10. Holland SM, Gallin JI (1998). “Evaluation of the patient with recurrent bacterial infections”. Annu Rev Med. 49: 185–99. doi:10.1146/annurev.med.49.1.185. PMID 9509258.
  11. Arbiser JL (1995). “Genetic immunodeficiencies: cutaneous manifestations and recent progress”. J Am Acad Dermatol. 33 (1): 82–9. PMID 7601952.
  12. Vizzard MA (2001). “Alterations in neuropeptide expression in lumbosacral bladder pathways following chronic cystitis”. J Chem Neuroanat. 21 (2): 125–38. PMID 11312054.
  13. Sant GR (2002). “Etiology, pathogenesis, and diagnosis of interstitial cystitis”. Rev Urol. 4 Suppl 1: S9–S15. PMC 1476007. PMID 16986036.
  14. Kind T, Cho E, Park TD, Deng N, Liu Z, Lee T; et al. (2016). “Interstitial Cystitis-Associated Urinary Metabolites Identified by Mass-Spectrometry Based Metabolomics Analysis”. Sci Rep. 6: 39227. doi:10.1038/srep39227. PMC 5156939. PMID 27976711.
  15. Friedlander JI, Shorter B, Moldwin RM (2012). “Diet and its role in interstitial cystitis/bladder pain syndrome (IC/BPS) and comorbid conditions”. BJU Int. 109 (11): 1584–91. doi:10.1111/j.1464-410X.2011.10860.x. PMID 22233286.
  16. Winnard KP, Dmitrieva N, Berkley KJ (2006). “Cross-organ interactions between reproductive, gastrointestinal, and urinary tracts: modulation by estrous stage and involvement of the hypogastric nerve”. Am J Physiol Regul Integr Comp Physiol. 291 (6): R1592–601. doi:10.1152/ajpregu.00455.2006. PMID 16946082.
  17. French LM, Bhambore N (2011). “Interstitial cystitis/painful bladder syndrome”. Am Fam Physician. 83 (10): 1175–81. PMID 21568251.
  18. Cystitis Cystica. Radiopaedia 2016. http://radiopaedia.org/articles/cystitis-cystica. Accessed on February 9, 2016
  19. Halder P, Mandal KC, Mukherjee S (2016). “Prolapsing cystitis cystica causing bladder outlet obstruction: An unusual complication”. Indian J Urol. 32 (4): 329–330. doi:10.4103/0970-1591.189718. PMC 5054670. PMID 27843222.
  20. Vrljicak K, Turudić D, Bambir I, Gradiski IP, Spajić B, Batinić D; et al. (2013). “Positive feedback loop for cystitis cystica: the effect of recurrent urinary tract infection on the number of bladder wall mucosa nodules”. Acta Clin Croat. 52 (4): 444–7. PMID 24696993.
  21. Varo Solís C, Bachiller Burgos J, Báez JM, Estudillo F, González Moreno D, Alvarez-Ossorio Fernández JL; et al. (2000). “[Glandular cystic cystitis]”. Actas Urol Esp. 24 (7): 594–8. PMID 11011454.
  22. Leutscher PD, Pedersen M, Raharisolo C, Jensen JS, Hoffmann S, Lisse I; et al. (2005). “Increased prevalence of leukocytes and elevated cytokine levels in semen from Schistosoma haematobium-infected individuals”. J Infect Dis. 191 (10): 1639–47. doi:10.1086/429334. PMID 15838790.
  23. Wakamiya T, Kuramoto T, Inagaki T (2016). “[Two Cases of Spontaneous Rupture of the Urinary Bladder Associated with Radiation Cystitis, Repaired with Omentum Covering]”. Hinyokika Kiyo. 62 (10): 545–548. doi:10.14989/ActaUrolJap_62_10_545. PMID 27919130.
  24. Russo P (2000). “Urologic emergencies in the cancer patient”. Semin Oncol. 27 (3): 284–98. PMID 10864217.
  25. PHILIPS FS, STERNBERG SS, CRONIN AP, VIDAL PM (1961). “Cyclophosphamide and urinary bladder toxicity”. Cancer Res. 21: 1577–89. PMID 14486208.
  26. Watson NA, Notley RG (1973). “Urological complications of cyclophosphamide”. Br J Urol. 45 (6): 606–9. PMID 4775738.
  27. Cox PJ (1979). “Cyclophosphamide cystitis and bladder cancer. A hypothesis”. Eur J Cancer. 15 (8): 1071–2. PMID 510344.
  28. Klastersky J (2003). “Side effects of ifosfamide”. Oncology. 65 Suppl 2: 7–10. doi:73351 Check |doi= value (help). PMID 14586140.
  29. Toma Y, Ishiki T, Nagahama K, Okumura K, Kamiyama T, Kohagura K; et al. (2009). “Penicillin G-induced hemorrhagic cystitis with hydronephrosis”. Intern Med. 48 (18): 1667–9. PMID 19755771.
  30. Pugachev AG, Kniaz’kina OM (2001). “[Traumatic postoperative cystitis in children]”. Urologiia (5): 41–5. PMID 11641980.
  31. Aydos MM, Memis A, Yakupoglu YK, Ozdal OL, Oztekin V (2001). “The use and efficacy of the American Urological Association Symptom Index in assessing the outcome of urethroplasty for post-traumatic complete posterior urethral strictures”. BJU Int. 88 (4): 382–4. PMID 11564026.
  32. Cunha BA, Lee P, Kaouris N, Raza M (2015). “The safety of nitrofurantoin for the treatment of nosocomial catheter-associated bacteriuria (CAB) and cystitis”. J Chemother. 27 (2): 122–3. doi:10.1179/1973947814Y.0000000202. PMID 25004793.
  33. Teal SB, Craven WM (2006). “Inadvertent vesicular placement of a vaginal contraceptive ring presenting as persistent cystitis”. Obstet Gynecol. 107 (2 Pt 2): 470–2. doi:10.1097/01.AOG.0000164072.91339.9e. PMID 16449153.
  34. Bilichenko SV, Maĭzel’s IG, Golovina EI, Arkhipov VV (2001). “[Bladder foreign body in a 4-year-old girl]”. Urologiia (3): 42–3. PMID 11505545.
  35. Worthington T, White J, Lambert P, Adlakha S, Elliott T (1999). “Beta-lactam-dependent coagulase-negative staphylococcus associated with urinary-tract infection”. Lancet. 354 (9184): 1097. doi:10.1016/S0140-6736(99)02474-5. PMID 10509508.
  36. Sievert DM, Ricks P, Edwards JR, Schneider A, Patel J, Srinivasan A; et al. (2013). “Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010”. Infect Control Hosp Epidemiol. 34 (1): 1–14. doi:10.1086/668770. PMID 23221186.
  37. Stamatiou K (2013). “Urinary retention due to benign tumor of the bladder neck in a woman; a rare case of papillary cystitis”. Urologia. 80 (1): 83–5. doi:10.5301/RU.2013.10716. PMID 23423685.
  38. Tzou KY, Chiang YT (2016). “Emphysematous Cystitis”. N Engl J Med. 375 (18): 1779. doi:10.1056/NEJMicm1509543. PMID 27806219.
  39. Hu SY, Lee BJ, Tsai CA, Hsieh MS (2016). “Concurrent emphysematous pyelonephritis, cystitis, and iliopsoas abscess from discitis in a diabetic woman”. Int J Infect Dis. 51: 105–106. doi:10.1016/j.ijid.2016.09.012. PMID 27637417.
  40. May T, Stein A, Molnar R, Dekel Y (2016). “Demonstrative Imaging of Emphysematous Cystitis”. Urol Case Rep. 6: 56–7. doi:10.1016/j.eucr.2016.03.001. PMC 4855983. PMID 27175347.
  41. Garde H, Useros E, Hernando A, Chávez C, Paños E, Quijano P; et al. (2015). “[Emphysematous cystitis: Report of 2 cases with different outcomes]”. Arch Esp Urol. 68 (7): 627–32. PMID 26331400.
  42. Grupper M, Kravtsov A, Potasman I (2007). “Emphysematous cystitis: illustrative case report and review of the literature”. Medicine (Baltimore). 86 (1): 47–53. doi:10.1097/MD.0b013e3180307c3a. PMID 17220755.
  43. Yi X, Lu H, Wu Y, Shen Y, Meng Q, Cheng J; et al. (2014). “Cystitis glandularis: A controversial premalignant lesion”. Oncol Lett. 8 (4): 1662–1664. doi:10.3892/ol.2014.2360. PMC 4156188. PMID 25202387.
  44. Semins MJ, Schoenberg MP (2007). “A case of florid cystitis glandularis”. Nat Clin Pract Urol. 4 (6): 341–5. doi:10.1038/ncpuro0814. PMID 17551538.
  45. IMMERGUT S, COTTLER ZR (1950). “Mucin producing adenocarcinoma of the bladder associated with cystitis follicularis and glandularis”. Urol Cutaneous Rev. 54 (9): 531–4. PMID 15443228.
  46. Bryan RT, Nicholls JH, Harrison RF, Jankowski JA, Wallace DM (2003). “The role of beta-catenin signaling in the malignant potential of cystitis glandularis”. J Urol. 170 (5): 1892–6. doi:10.1097/01.ju.0000092740.51330.39. PMID 14532801.
  47. Tsai YC, Birder L, Kuo HC (2016). “Abnormal Sensory Protein Expression and Urothelial Dysfunction in Ketamine-Related Cystitis in Humans”. Int Neurourol J. 20 (3): 197–202. doi:10.5213/inj.1632634.317. PMC 5083834. PMID 27706016.
  48. Scholes D, Hawn TR, Roberts PL, Li SS, Stapleton AE, Zhao LP; et al. (2010). “Family history and risk of recurrent cystitis and pyelonephritis in women”. J Urol. 184 (2): 564–9. doi:10.1016/j.juro.2010.03.139. PMC 3665335. PMID 20639019.
  49. Zhong YH, Fang Y, Zhou JZ, Tang Y, Gong SM, Ding XQ (2011). “Effectiveness and safety of patient initiated single-dose versus continuous low-dose antibiotic prophylaxis for recurrent urinary tract infections in postmenopausal women: a randomized controlled study”. J Int Med Res. 39 (6): 2335–43. PMID 22289552.
  50. Ples R, Méchaï F, Champiat B, Droupy S, Huerre M, Guettier C; et al. (2011). “[Pseudotumoral toxoplasmic cystitis revealing acquired immunodeficiency syndrome]”. Ann Pathol. 31 (1): 46–9. doi:10.1016/j.annpat.2010.11.001. PMID 21349389.
  51. 51.0 51.1 Libre Pathology https://librepathology.org/wiki/File:Cystitis_cystica_-_alt_–_intermed_mag.jpg Accessed on Jan 13, 2017
  52. 52.0 52.1 Libre Pathology https://librepathology.org/wiki/File:Cystitis_cystica_et_glandularis_-_alt_–_intermed_mag.jpg Accessed on Jan 13, 2017

Template:WH Template:WS

Causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Steven C. Campbell, M.D., Ph.D. Associate Editor(s)-in-Chief: Maliha Shakil, M.D. [2], Usama Talib, BSc, MD [3]

Overview

Infections are the most common cause of cystitis. More than 80% of cases of cystitis are caused by Escherichia coli (E. Coli), a bacterium found in the lower gastrointestinal tract. Some viruses, fungi and parasites can rarely cause cystitis. Other causes of cystitis include certain medications, iatrogenic causes, pelvic inflammatory disease, trauma, and radiation therapy.

Causes

Common Causes

Infections are the most common cause of cystitis. More than 80% of cases of cystitis are caused by Escherichia coli (E. Coli), a bacterium found in the lower gastrointestinal tract. Pathogens causing cystitis include: [1][2][3][4][5]

Less Common/Rare Causes

Some less common or rare causes of cystitis may include:[6][7]

Hemorrhagic Causes

Hemorrhagic cystitis can be caused by:[4][8][9][5]

Causes by Organ System

The causes of cystitis with rest to organ system can be classified as:[7][10][11][12][13][4][5][8][14][15][3][16][17][18][19]

Cardiovascular No underlying causes
Chemical / poisoning Chemical cystitis
Dermatologic No underlying causes
Drug Side Effect Allopurinol, BCG vaccine, Cetirizine, Cyclophosphamide, Cytarabine, Danazol, Doxorubicin, drug induced cystitis, hexaminolevulinate, Ifosfamide, Leflunomide, Methotrexate, NSAIDs, Oxaprozin, Pramipexole, Sertraline, Tiagabine, Tiaprofenic acid, Ticarcillin, Topiramate, Tranilast
Ear Nose Throat No underlying causes
Endocrine No underlying causes
Environmental No underlying causes
Gastroenterologic No underlying causes
Genetic No underlying causes
Hematologic No underlying causes
Iatrogenic Cystoscopy, radiotherapy
Infectious Disease Candida, chlamydia, E. coli, enterobacter, gonorrhea, klebsiella, prostatitis, pseudomonas aeruginosa, schistosomiasis, serratia, staphylococcus saprophyticus, trichomoniasis, tuberculosis
Musculoskeletal / Ortho No underlying causes
Neurologic No underlying causes
Nutritional / Metabolic No underlying causes
Obstetric/Gynecologic No underlying causes
Oncologic No underlying causes
Opthalmologic No underlying causes
Overdose / Toxicity No underlying causes
Psychiatric No underlying causes
Pulmonary No underlying causes
Renal / Electrolyte No underlying causes
Rheum / Immune / Allergy Autoimmune interstitial cystitis
Sexual No underlying causes
Trauma Physical trauma
Urologic Autoimmune interstitial cystitis, interstitial cystitis, urethritis
Dental No underlying causes
Miscellaneous Foreign body cystitis

Causes in Alphabetical Order

References

  1. Ronald A (2002). “The etiology of urinary tract infection: traditional and emerging pathogens”. Am J Med. 113 Suppl 1A: 14S–19S. PMID 12113867.
  2. Aydos MM, Memis A, Yakupoglu YK, Ozdal OL, Oztekin V (2001). “The use and efficacy of the American Urological Association Symptom Index in assessing the outcome of urethroplasty for post-traumatic complete posterior urethral strictures”. BJU Int. 88 (4): 382–4. PMID 11564026.
  3. 3.0 3.1 Bilichenko SV, Maĭzel’s IG, Golovina EI, Arkhipov VV (2001). “[Bladder foreign body in a 4-year-old girl]”. Urologiia (3): 42–3. PMID 11505545.
  4. 4.0 4.1 4.2 Cox PJ (1979). “Cyclophosphamide cystitis and bladder cancer. A hypothesis”. Eur J Cancer. 15 (8): 1071–2. PMID 510344.
  5. 5.0 5.1 5.2 Russo P (2000). “Urologic emergencies in the cancer patient”. Semin Oncol. 27 (3): 284–98. PMID 10864217.
  6. Ples R, Méchaï F, Champiat B, Droupy S, Huerre M, Guettier C; et al. (2011). “[Pseudotumoral toxoplasmic cystitis revealing acquired immunodeficiency syndrome]”. Ann Pathol. 31 (1): 46–9. doi:10.1016/j.annpat.2010.11.001. PMID 21349389.
  7. 7.0 7.1 Teles F, Santos LG, Tenório CE, Marinho MR, Moraes SR, Câmara DB; et al. (2016). “Lupus cystitis presenting with hidronephrosis and gastrointestinal involvement”. J Bras Nefrol. 38 (4): 478–482. doi:10.5935/0101-2800.20160077. PMID 28001179.
  8. 8.0 8.1 Wakamiya T, Kuramoto T, Inagaki T (2016). “[Two Cases of Spontaneous Rupture of the Urinary Bladder Associated with Radiation Cystitis, Repaired with Omentum Covering]”. Hinyokika Kiyo. 62 (10): 545–548. doi:10.14989/ActaUrolJap_62_10_545. PMID 27919130.
  9. Toma Y, Ishiki T, Nagahama K, Okumura K, Kamiyama T, Kohagura K; et al. (2009). “Penicillin G-induced hemorrhagic cystitis with hydronephrosis”. Intern Med. 48 (18): 1667–9. PMID 19755771.
  10. Hooton TM, Stamm WE (1997). “Diagnosis and treatment of uncomplicated urinary tract infection”. Infect Dis Clin North Am. 11 (3): 551–81. PMID 9378923.
  11. Friedlander JI, Shorter B, Moldwin RM (2012). “Diet and its role in interstitial cystitis/bladder pain syndrome (IC/BPS) and comorbid conditions”. BJU Int. 109 (11): 1584–91. doi:10.1111/j.1464-410X.2011.10860.x. PMID 22233286.
  12. Leutscher PD, Pedersen M, Raharisolo C, Jensen JS, Hoffmann S, Lisse I; et al. (2005). “Increased prevalence of leukocytes and elevated cytokine levels in semen from Schistosoma haematobium-infected individuals”. J Infect Dis. 191 (10): 1639–47. doi:10.1086/429334. PMID 15838790.
  13. Okazaki S, Hori J, Kita M, Yamaguchi S, Kawakami N, Kakizaki H (2014). “[A case of eosinophilic cystitis mimicking an invasive bladder cancer]”. Hinyokika Kiyo. 60 (12): 635–9. PMID 25602481.
  14. Cunha BA, Lee P, Kaouris N, Raza M (2015). “The safety of nitrofurantoin for the treatment of nosocomial catheter-associated bacteriuria (CAB) and cystitis”. J Chemother. 27 (2): 122–3. doi:10.1179/1973947814Y.0000000202. PMID 25004793.
  15. Teal SB, Craven WM (2006). “Inadvertent vesicular placement of a vaginal contraceptive ring presenting as persistent cystitis”. Obstet Gynecol. 107 (2 Pt 2): 470–2. doi:10.1097/01.AOG.0000164072.91339.9e. PMID 16449153.
  16. Grimsby GM, Tyson MD, Salevitz B, Smith ML, Castle EP (2012). “Bladder Outlet Obstruction Secondary to a Brunn’s Cyst”. Curr Urol. 6 (1): 50–2. doi:10.1159/000338871. PMC 3783323. PMID 24917712.
  17. Tzou KY, Chiang YT (2016). “Emphysematous Cystitis”. N Engl J Med. 375 (18): 1779. doi:10.1056/NEJMicm1509543. PMID 27806219.
  18. Echols RM, Tosiello RL, Haverstock DC, Tice AD (1999). “Demographic, clinical, and treatment parameters influencing the outcome of acute cystitis”. Clin Infect Dis. 29 (1): 113–9. doi:10.1086/520138. PMID 10433573.
  19. de Cueto M, Aliaga L, Alós JI, Canut A, Los-Arcos I, Martínez JA; et al. (2016). “Executive summary of the diagnosis and treatment of urinary tract infection: Guidelines of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC)”. Enferm Infecc Microbiol Clin. doi:10.1016/j.eimc.2016.11.005. PMID 28017477.
  20. Chang PC, Hsu YC, Hsieh ML, Huang ST, Huang HC, Chen Y (2016). “A pilot study on Trichomonas vaginalis in women with recurrent urinary tract infections”. Biomed J. 39 (4): 289–294. doi:10.1016/j.bj.2015.11.005. PMID 27793272.

Template:WH Template:WS

Differentiating Cystitis from other Diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Maliha Shakil, M.D. [2], Usama Talib, BSc, MD [3]

Overview

Cystitis must be differentiated from other causes of dysuria such as acute pyelonephritis, urethritis, prostatitis, vulvovaginitis, urethral strictures or diverticula, benign prostatic hyperplasia and neoplasms such as renal cell carcinoma and cancers of the bladder, prostate, and penis. It must also be differentiated from sexually transmitted diseases such as syphilis.[1][2][3]

Differential Diagnosis

Diseases Symptoms Signs Diagnosis Other Features
Abdominal pain Bowel habits Rebound tenderness Guarding Genitourinary signs Lab findings Imaging
GI diseases Colorectal cancer LLQ Constipation CT scan, x-ray and MRI used to show metastasis
Inflammatory bowel disease LLQ Bloody diarrhea
  • Leukocytosis
Colonoscopy and tissue sampling are recommended for differentiating between Crohn’s disease and ulcerative colitis.
Diverticulitis LLQ Constipation

Or

Diarrhea

+ + CT scan shows evidence of inflammation
Appendicitis LLQ / RRQ Constipation + + Ultrasound shows evidence of inflammation Nausea & vomiting,decreased appetite
Strangulated hernia LLQ
  • No specific tests
  • CT scan used to detect the hernia and to show if it is single or multiple
Gentiourinary diseases Cystitis LLQ +
  • Suprapubic tenderness
  • X ray is done to probe the suspicion of emphysematous cystitis.
  • CT scan shows gas in the bladder in cases of emphysematous cystitis.
Prostatitis LLQ

Groin pain

  • Tender and enlarged
Pelvic inflammatory disease Bilateral +
  • Purulent vaginal discharge
Transvaginal utrasonography
Gynecological diseases Endometritis LLQ + +
  • No specific tests
  • Ultrasound is helpful to rule out other differential diagnosis such as pelvic abscess, thrombosis and masses
  • Vaginal discharge
  • Vaginal bleeding
Salpingitis LLQ/ RLQ +/- +/-
  • Leukocytosis
Pelvic ultrasound
  • Vaginal discharge
  • The differential diagnoses of Cystitis include:[2][3][10]

Cystitis must also be differentiated from sexually transmitted diseases, such as syphilis.[1]

Cystitis can be differentiated from other diseases that cause lower urinary tract irritation symptoms, such as: dysuria, urgency and frequency in addition to urethral dyscharge , the differential list include: urethritis, cervicitis, vulvovaginitis, epididimitis, prostatitis , and syphilis.[3][11][12][13]

Disease Findings
Cystitis Bladder inflammation, Features with increased frequency and urgency, dysuria, and suprapubic pain. Is more common among women. E.coli is the most common pathogen[14][15][16][17].
Urethritis infection of the urethra,causes dysuria and urethral discharge[12][18][19]
Bacterial vulvovaginitis Presents with dysuria and pruritus, Vaginal discharge and odor are almost always present, caused by Gardnerella species[20].
Cervicitis Often asymptomatic,some women have an abnormal vaginal discharge and vaginal bleeding (especially after sexual intercourse)[21]
Prostatitis bacterial infection of the prostate,causes discomfort during ejaculation[22]
Epididymitis Presents with scrotal pain and swelling accompanied by fever and lower urinary tract irritation symptoms(dysuria and frequency)[23].
Syphilis Presents with generalized systemic symptoms such as malaise, fatigue, headache and fever. Skin eruptions may be subtle and asymptomatic. It is classically described as 1) non-pruritic bilateral symmetrical mucocutaneous rash; 2) non-tender regional lymphadenopathy; 3) condylomata lata; and 4) patchy alopecia.[11]

References

  1. 1.0 1.1 Workowski, KA.; Berman, S.; Workowski, KA.; Bauer, H.; Bachman, L.; Burstein, G.; Eckert, L.; Geisler, WM.; Ghanem, K. (2010). “Sexually transmitted diseases treatment guidelines, 2010”. MMWR Recomm Rep. 59 (RR-12): 1–110. PMID 21160459. Unknown parameter |month= ignored (help)
  2. 2.0 2.1 Bremnor JD, Sadovsky R (2002). “Evaluation of dysuria in adults”. Am Fam Physician. 65 (8): 1589–96. PMID 11989635.
  3. 3.0 3.1 3.2 Kurowski K (1998). “The woman with dysuria”. Am Fam Physician. 57 (9): 2155–64, 2169–70. PMID 9606306.
  4. Laurell H, Hansson LE, Gunnarsson U (2007). “Acute diverticulitis–clinical presentation and differential diagnostics”. Colorectal Dis. 9 (6): 496–501, discussion 501-2. doi:10.1111/j.1463-1318.2006.01162.x. PMID 17573742.
  5. Hardin, M. Acute Appendicitis: Review and Update. Am Fam Physician”.1999, Nov 1;60(7):2027-2034
  6. Hanauer SB (1996). “Inflammatory bowel disease”. N Engl J Med. 334 (13): 841–8. doi:10.1056/NEJM199603283341307. PMID 8596552.
  7. Cystitis-acute. MedlinePlus.https://www.nlm.nih.gov/medlineplus/ency/article/000526.htm Accessed on February 9, 2016
  8. Prostatitis – bacterial. NLM Medline Plus 2016. https://www.nlm.nih.gov/medlineplus/ency/article/000519.htm. Accessed on March 2, 2016
  9. Ford GW, Decker CF (2016). “Pelvic inflammatory disease”. Dis Mon. 62 (8): 301–5. doi:10.1016/j.disamonth.2016.03.015. PMID 27107781.
  10. IMMERGUT S, COTTLER ZR (1950). “Mucin producing adenocarcinoma of the bladder associated with cystitis follicularis and glandularis”. Urol Cutaneous Rev. 54 (9): 531–4. PMID 15443228.
  11. 11.0 11.1 Moore, Zack S; Seward, Jane F; Lane, J Michael (2006). “Smallpox”. The Lancet. 367 (9508): 425–435. doi:10.1016/S0140-6736(06)68143-9. ISSN 0140-6736.
  12. 12.0 12.1 Taylor-Robinson D (1996). “The history of nongonococcal urethritis. Thomas Parran Award Lecture”. Sex Transm Dis. 23 (1): 86–91. PMID 8801649.
  13. Bennett, John (2015). Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. Philadelphia, PA: Elsevier/Saunders. ISBN 9781455748013.
  14. Stephen Bent, Brahmajee K. Nallamothu, David L. Simel, Stephan D. Fihn & Sanjay Saint (2002). “Does this woman have an acute uncomplicated urinary tract infection?”. JAMA. 287 (20): 2701–2710. PMID 12020306. Unknown parameter |month= ignored (help)
  15. W. E. Stamm (1981). “Etiology and management of the acute urethral syndrome”. Sexually transmitted diseases. 8 (3): 235–238. PMID 7292216. Unknown parameter |month= ignored (help)
  16. W. E. Stamm, K. F. Wagner, R. Amsel, E. R. Alexander, M. Turck, G. W. Counts & K. K. Holmes (1980). “Causes of the acute urethral syndrome in women”. The New England journal of medicine. 303 (8): 409–415. doi:10.1056/NEJM198008213030801. PMID 6993946. Unknown parameter |month= ignored (help)
  17. Leonie G. M. Giesen, Grainne Cousins, Borislav D. Dimitrov, Floris A. van de Laar & Tom Fahey (2010). “Predicting acute uncomplicated urinary tract infection in women: a systematic review of the diagnostic accuracy of symptoms and signs”. BMC family practice. 11: 78. doi:10.1186/1471-2296-11-78. PMID 20969801.
  18. Bennett, John (2015). Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. Philadelphia, PA: Elsevier/Saunders. ISBN 9781455748013.
  19. Brill JR (2010). “Diagnosis and treatment of urethritis in men”. Am Fam Physician. 81 (7): 873–8. PMID 20353145.
  20. Daniel V. Landers, Harold C. Wiesenfeld, R. Phillip Heine, Marijane A. Krohn & Sharon L. Hillier (2004). “Predictive value of the clinical diagnosis of lower genital tract infection in women”. American journal of obstetrics and gynecology. 190 (4): 1004–1010. doi:10.1016/j.ajog.2004.02.015. PMID 15118630. Unknown parameter |month= ignored (help)
  21. Kimberly A. Workowski & Gail A. Bolan (2015). “Sexually transmitted diseases treatment guidelines, 2015”. MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 64 (RR-03): 1–137. PMID 26042815. Unknown parameter |month= ignored (help)
  22. Felix Millan-Rodriguez, J. Palou, Anna Bujons-Tur, Mireia Musquera-Felip, Carlota Sevilla-Cecilia, Marc Serrallach-Orejas, Carlos Baez-Angles & Humberto Villavicencio-Mavrich (2006). “Acute bacterial prostatitis: two different sub-categories according to a previous manipulation of the lower urinary tract”. World journal of urology. 24 (1): 45–50. doi:10.1007/s00345-005-0040-4. PMID 16437219. Unknown parameter |month= ignored (help)
  23. A. Stewart, S. S. Ubee & H. Davies (2011). “Epididymo-orchitis”. BMJ (Clinical research ed.). 342: d1543. PMID 21490048.

Template:WH Template:WS

Epidemiology and Demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Maliha Shakil, M.D. [2], Usama Talib, BSc, MD [3]

Overview

Urinary tract infections are found more frequently in women than in men. It is estimated that more than 30% of women will experience at least one episode of cystitis. Of these 30%, 20% women will have recurrent cystitis. The case-fatality rate/mortality rate of uncomplicated cystitis is approximately zero. Females are more commonly affected with cystitis than males. The female to male ratio is 4 to 1. Acute uncomplicated cystitis commonly affects women ages 18-39 years. There is no racial predilection to cystitis. Cystitis is a common disease that affect everyone, mostly women, worldwide.

Epidemiology

Incidence

  • It is estimated that one third of the women population has at least one episode of cystitis in their lifetime. Of these many will have recurrent cystitis.
  • 81% of the total UTIs in the world occur in women.
  • 27% of women with an episode of UTI have another episode within the next 6 months while 48% within the next 12 months.[1][2]
  • More than 7 million uncomplicated UTIs occur in the US per year.[3]
  • Sexually active women are known to have a higher incidence of UTIs than women of other categories.
  • The incidence of cystitis in women is 5-7 per year per 100,000 while that in same age men is 50-80 per 100000.[4][5]
  • The incidence of UTI is higher in sexually active women than postmenopausal women.[6][7][4]
  • There is a higher incidence of urinary tract infection in immunocompromised, elderly, diabetic, and individuals with indwelling catheters.[8][9]

Prevalence

  • Almost 30% of the women will experience at least one episode of cystitis during their life span. Of these 30%, 20% of these women will have recurrent cystitis.[1]

Case-fatality rate/Mortality rate

  • The case-fatality rate/mortality rate of uncomplicated cystitis is approximately zero.[10]

Age

  • Acute uncomplicated cystitis commonly affects women ages 18-39 years.[11][3][12]
  • UTIs are less frequent in 2-13 years old girls.
  • Urinary tract infections can rarely occur in boys in the first year after birth in the presence of a structural defect or due to lack of circumcision.

Race

  • There is no racial predilection to cystitis.

Gender

  • Females are more commonly affected with cystitis than males. The female to male ratio is 4 to 1.[13][14]

Region

  • Cystitis is a common disease that affect everyone, mostly women, worldwide.

References

  1. 1.0 1.1 Kurowski K (1998). “The woman with dysuria”. Am Fam Physician. 57 (9): 2155–64, 2169–70. PMID 9606306.
  2. Salvatore S, Salvatore S, Cattoni E, Siesto G, Serati M, Sorice P; et al. (2011). “Urinary tract infections in women”. Eur J Obstet Gynecol Reprod Biol. 156 (2): 131–6. doi:10.1016/j.ejogrb.2011.01.028. PMID 21349630.
  3. 3.0 3.1 Stamm WE, Norrby SR (2001). “Urinary tract infections: disease panorama and challenges”. J Infect Dis. 183 Suppl 1: S1–4. doi:10.1086/318850. PMID 11171002.
  4. 4.0 4.1 Hooton TM, Scholes D, Hughes JP, Winter C, Roberts PL, Stapleton AE; et al. (1996). “A prospective study of risk factors for symptomatic urinary tract infection in young women”. N Engl J Med. 335 (7): 468–74. doi:10.1056/NEJM199608153350703. PMID 8672152.
  5. Krieger JN, Ross SO, Simonsen JM (1993). “Urinary tract infections in healthy university men”. J Urol. 149 (5): 1046–8. PMID 8483206.
  6. Jackson, Sara L., et al. “Predictors of urinary tract infection after menopause: a prospective study.” The American journal of medicine 117.12 (2004): 903-911.
  7. Hooton TM (2012). “Clinical practice. Uncomplicated urinary tract infection”. N Engl J Med. 366 (11): 1028–37. doi:10.1056/NEJMcp1104429. PMID 22417256.
  8. Nicolle, Lindsay E., et al. “Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults.” Clinical Infectious Diseases (2005): 643-654.
  9. Woodford HJ, George J (2011). “Diagnosis and management of urinary infections in older people”. Clin Med (Lond). 11 (1): 80–3. PMID 21404794.
  10. Molander U, Arvidsson L, Milsom I, Sandberg T (February 2000). “A longitudinal cohort study of elderly women with urinary tract infections”. Maturitas. 34 (2): 127–31. PMID 10714907.
  11. Hooton TM, Besser R, Foxman B, Fritsche TR, Nicolle LE (2004). “Acute uncomplicated cystitis in an era of increasing antibiotic resistance: a proposed approach to empirical therapy”. Clin Infect Dis. 39 (1): 75–80. doi:10.1086/422145. PMID 15206056.
  12. Bhat RG, Katy TA, Place FC (2011). “Pediatric urinary tract infections”. Emerg Med Clin North Am. 29 (3): 637–53. doi:10.1016/j.emc.2011.04.004. PMID 21782079.
  13. Colgan R, Williams M (2011). “Diagnosis and treatment of acute uncomplicated cystitis”. Am Fam Physician. 84 (7): 771–6. PMID 22010614.
  14. Geerlings SE (2016). “Clinical Presentations and Epidemiology of Urinary Tract Infections”. Microbiol Spectr. 4 (5). doi:10.1128/microbiolspec.UTI-0002-2012. PMID 27780014.

Template:WH Template:WS

Risk Factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Steven C. Campbell, M.D., Ph.D. Associate Editor(s)-in-Chief: Maliha Shakil, M.D. [2], Usama Talib, BSc, MD [3]

Overview

Common risk factors in the development of cystitis include female gender, sexual intercourse, diabetes, pregnancy, catheterization, fecal incontinence, old age, and immobility. Some foods are thought to have a role in increasing the risk of cystitis such as vitamin C, coffee or tea, carbonated and alcoholic drinks, citrus fruit, or spicy foods.

Risk Factors

Common risk factors in the development of cystitis include:[1][2][3][4][5][6][7][8][9][10]

General Risk Factors

Conditions

Medications and Procedures

Foods Increasing Risk of Cystitis

The following foods are thought to have a role in increasing the risk of cystitis:[11]

  • Spicy foods
  • Citrus fruit
  • Carbonated and alcoholic drinks
  • Coffee or tea
  • Vitamin C

References

  1. Platt R, Polk BF, Murdock B, Rosner B (1986). “Risk factors for nosocomial urinary tract infection”. Am J Epidemiol. 124 (6): 977–85. PMID 3776980.
  2. Cystitis-acute. MedlinePlus.https://www.nlm.nih.gov/medlineplus/ency/article/000526.htm Accessed on February 9, 2016
  3. Hooton TM (2000). “Pathogenesis of urinary tract infections: an update”. J Antimicrob Chemother. 46 Suppl A: 1–7. PMID 10969044.
  4. Nicolle LE (2008). “Uncomplicated urinary tract infection in adults including uncomplicated pyelonephritis”. Urol Clin North Am. 35 (1): 1–12, v. doi:10.1016/j.ucl.2007.09.004. PMID 18061019.
  5. Zhong YH, Fang Y, Zhou JZ, Tang Y, Gong SM, Ding XQ (2011). “Effectiveness and safety of patient initiated single-dose versus continuous low-dose antibiotic prophylaxis for recurrent urinary tract infections in postmenopausal women: a randomized controlled study”. J Int Med Res. 39 (6): 2335–43. PMID 22289552.
  6. Nicolle LE (2001). “A practical guide to antimicrobial management of complicated urinary tract infection”. Drugs Aging. 18 (4): 243–54. PMID 11341472.
  7. Franco AV (2005). “Recurrent urinary tract infections”. Best Pract Res Clin Obstet Gynaecol. 19 (6): 861–73. doi:10.1016/j.bpobgyn.2005.08.003. PMID 16298166.
  8. Scholes D, Hawn TR, Roberts PL, Li SS, Stapleton AE, Zhao LP; et al. (2010). “Family history and risk of recurrent cystitis and pyelonephritis in women”. J Urol. 184 (2): 564–9. doi:10.1016/j.juro.2010.03.139. PMC 3665335. PMID 20639019.
  9. Ples R, Méchaï F, Champiat B, Droupy S, Huerre M, Guettier C; et al. (2011). “[Pseudotumoral toxoplasmic cystitis revealing acquired immunodeficiency syndrome]”. Ann Pathol. 31 (1): 46–9. doi:10.1016/j.annpat.2010.11.001. PMID 21349389.
  10. Teles F, Santos LG, Tenório CE, Marinho MR, Moraes SR, Câmara DB; et al. (2016). “Lupus cystitis presenting with hidronephrosis and gastrointestinal involvement”. J Bras Nefrol. 38 (4): 478–482. doi:10.5935/0101-2800.20160077. PMID 28001179.
  11. Friedlander JI, Shorter B, Moldwin RM (2012). “Diet and its role in interstitial cystitis/bladder pain syndrome (IC/BPS) and comorbid conditions”. BJU Int. 109 (11): 1584–91. doi:10.1111/j.1464-410X.2011.10860.x. PMID 22233286.

Template:WH Template:WS

Screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Usama Talib, BSc, MD [2]

Overview

Screening is not recommended for cystitis in a general population. However, pregnancy is an indication for screening for the presence of bacteria in the urine, as this may require aggressive treatment unlike other settings. Other situations that require screening for asymptomatic bacteriuria are prior to urologic surgery or for the research purposes.

Screening

  • Screening is not recommended for cystitis in a general population.
  • Screening is recommended to detect bacterial presence in the urine of pregnant women. Urine culture is done to screen this population for bacterial presence.[1][2]

References

  1. Glaser AP, Schaeffer AJ (2015). “Urinary Tract Infection and Bacteriuria in Pregnancy”. Urol Clin North Am. 42 (4): 547–60. doi:10.1016/j.ucl.2015.05.004. PMID 26475951.
  2. Matuszkiewicz-Rowińska J, Małyszko J, Wieliczko M (2015). “Urinary tract infections in pregnancy: old and new unresolved diagnostic and therapeutic problems”. Arch Med Sci. 11 (1): 67–77. doi:10.5114/aoms.2013.39202. PMC 4379362. PMID 25861291.
  3. Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM; et al. (2005). “Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults”. Clin Infect Dis. 40 (5): 643–54. doi:10.1086/427507. PMID 15714408.

Template:WH Template:WS

Natural History, Complications and Prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Maliha Shakil, M.D. [2], Usama Talib, BSc, MD [3]

Overview

Approximately 50% of patients with acute uncomplicated cystitis will recover without treatment within a few days or weeks. If left untreated, some patients with cystitis may progress to develop recurrent infection, pyelonephritis, hematuria, and rarely renal failure. Prognosis is generally good. The majority of patients with cystitis do not have recurrence or complications after treatment.

Natural History

Complications

Complications of cystitis include:[1][2][3][4][5][6][7][8]

Prognosis

  • Prognosis is generally good.
  • The majority of patients with cystitis have a complete resolution of symptoms after treatment.[9]
  • Recurrence is the most common complication of cystitis.
  • Every UTI increases the risk of subsequent UTI.
  • An E.Coli increases the chance or recurrent infection at least three times.
  • Following the first UTI, 27% of women during the first 6 months and 48% of women during the first 12 months are considered to undergo another urinary tract infection.[10][11]

References

  1. 1.0 1.1 Ząbkowski T, Jurkiewicz B, Saracyn M (2015). “Treatment of Recurrent Bacterial Cystitis by Intravesical Instillations of Hyaluronic Acid”. Urol J. 12 (3): 2192–5. PMID 26135937.
  2. 2.0 2.1 Hannan TJ, Roberts PL, Riehl TE, van der Post S, Binkley JM, Schwartz DJ; et al. (2014). “Inhibition of Cyclooxygenase-2 Prevents Chronic and Recurrent Cystitis”. EBioMedicine. 1 (1): 46–57. doi:10.1016/j.ebiom.2014.10.011. PMC 4457352. PMID 26125048.
  3. IMMERGUT S, COTTLER ZR (1950). “Mucin producing adenocarcinoma of the bladder associated with cystitis follicularis and glandularis”. Urol Cutaneous Rev. 54 (9): 531–4. PMID 15443228.
  4. Tanaka T, Yamashita S, Mitsuzuka K, Yamada S, Kaiho Y, Nakagawa H; et al. (2013). “Encrusted cystitis causing postrenal failure”. J Infect Chemother. 19 (6): 1193–5. doi:10.1007/s10156-013-0603-z. PMID 23605319.
  5. Freyer PJ (1907). “TOTAL ENUCLEATION OF THE PROSTATE FOR RADICAL CURE OF ENLARGEMENT OF THAT ORGAN: A FURTHER SERIES OF 119 CASES OF THE OPERATION”. Br Med J. 1 (2410): 551–5. PMC 2356894. PMID 20763110.
  6. Shimi A, Boumedian A, Elbakouri N, Derkaoui A, Khatouf M (2015). “[A rare cause of septic shock in diabetic: emphysematous cystitis complicated with bladder rupture]”. Pan Afr Med J. 20: 415. doi:10.11604/pamj.2015.20.415.6757. PMC 4524907. PMID 26301019.
  7. Kuriyama A, Nakajo K (2014). “Emphysematous cystitis and bacteremia caused by Escherichia coli”. Intern Med. 53 (4): 349. PMID 24531100.
  8. Kauffman CA, Vazquez JA, Sobel JD, Gallis HA, McKinsey DS, Karchmer AW; et al. (2000). “Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group”. Clin Infect Dis. 30 (1): 14–8. doi:10.1086/313583. PMID 10619726.
  9. Urinary Tract Infections in Adults. NIDDK 2016. http://www.niddk.nih.gov/health-information/health-topics/urologic-disease/urinary-tract-infections-in-adults/Pages/facts.aspx. Accessed on February 9, 2016
  10. Foxman B, Gillespie B, Koopman J, Zhang L, Palin K, Tallman P; et al. (2000). “Risk factors for second urinary tract infection among college women”. Am J Epidemiol. 151 (12): 1194–205. PMID 10905532.
  11. Salvatore S, Salvatore S, Cattoni E, Siesto G, Serati M, Sorice P; et al. (2011). “Urinary tract infections in women”. Eur J Obstet Gynecol Reprod Biol. 156 (2): 131–6. doi:10.1016/j.ejogrb.2011.01.028. PMID 21349630.

Template:WH Template:WS

Diagnosis

Diagnosis

Diagnostic study of choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X-Ray Findings | Echocardiography and Ultrasound | CT-Scan Findings | MRI Findings | Other Imaging Findings | Other Diagnostic Studies

Treatment

Treatment

Medical Therapy | Intervention | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case Studies

Case #1

Related Chapters

Template:WH Template:WS

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH